Rhodes Jason P

DirectorDyne Therapeutics, Inc. (DYN) · full profile →Form 4 · filed Jun 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.6M
Net Open-Market Flow
-$5.6M
Transactions
9
9 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 25, 2026Sell(S)5K$21.10$106K1.1M
Jun 25, 2026Sell(S)13K$21.10$268K4.7M
Jun 25, 2026Sell(S)6K$21.10$135K1.5M
Jun 24, 2026Sell(S)25K$21.02$534K1.5M
Jun 24, 2026Sell(S)51K$21.02$1.1M4.8M
Jun 24, 2026Sell(S)20K$21.02$420K1.1M
Jun 23, 2026Sell(S)78K$21.13$1.6M4.8M
Jun 23, 2026Sell(S)31K$21.13$650K1.1M
Jun 23, 2026Sell(S)39K$21.13$827K1.5M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001577014-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly: